Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas… (NCT06086002) | Clinical Trial Compass
CompletedNot Applicable
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
South Korea20 participantsStarted 2023-09-18
Plain-language summary
To compare safety and efficacy of microwave ablation with simultaneous ablation using two antennas versus overlapping ablation with single antenna for small hepatocellular carcinoma
Who can participate
Age range20 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Child-Pugh Class A or B
* chronic hepatitis B or chronic hepatitis C or liver cirrhosis
* presence of hepatocellular carcinoma (HCC) confirmed by pathology or imaging studies including contrast enhanced computed tomography (CT) or magnetic resonance imaging (MRI) according to Liver Imaging Reporting and Data System (LI-RADS) v2018
* single lesion less than or equal to 3 cm, or up to 3 lesions, each greater than less than or equal to 3 cm at the time of locoregional treatment
Exclusion Criteria:
* number of recurrent HCCs, equal or more than 3
* largest recurrent HCC size over 3 cm
* presence of vascular invasion by HCC
* diffuse infiltrative type HCC
* HCCs located less than 5 mm from central bile duct or large portal vein or large hepatic vein
* platelet count less than 40,000 per mm3 or International Normalized Ratio (INR) prolongation over 50%
* presence of extrahepatic metastasis
What they're measuring
1
Number of Participants with Technical Success
Timeframe: Immediately after ablation
2
Number of Participants with Technique Efficacy at 1 Month